Screening Tool for Malnutrition, Sarcopenia, and Cachexia
ASUST-MSC
Development and Validation of a New Tool for Simultaneous Screening of Malnutrition, Sarcopenia, and Cachexia in Older Adults
1 other identifier
observational
300
1 country
1
Brief Summary
There is an accumulating evidence of the overlap and frequent co-occurrence of twasting conditions in older adults. Those conditions include malnutrition, sarcopenia, and cachexia, Therefore , a tool capable of simultaneously screening for all three conditions is imperative. In this study, we developed and validated a new tool for the simultaneous screening of muscle wasting diseases in older adults. The diagnostic accuracy of the new tool was compared to other validated screening tools including the Mini Nutritional Assessment-Short Form (MNA-SF), the Short Nutritional Assessment Questionnaire (SNAQ), and the Simple Questionnaire to Rapidly Diagnose Sarcopenia (SARC-F).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 23, 2024
CompletedJuly 23, 2024
July 1, 2024
11 months
July 3, 2024
July 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
reliability of a new tool for the simultaneous screening of muscle wasting diseases in older adults
Relaibility; Cronbach's alpha coefficient was used to evaluate the internal consistency.
10 months
validity of a new tool for the simultaneous screening of muscle wasting diseases in older adults
Validity; Spearman's correlation coefficient was used to examine construct validity of the new tool
10 months
Secondary Outcomes (1)
The diagnostic accuracy of the new tool
10 months
Interventions
25 items dichotomous questionnaire
Eligibility Criteria
300 older participants aged 60 years old and above who were admitted to Ain Shams University Hospitals or interviewed at the hospital clinic
You may qualify if:
- Participants Aged 65 years and older, who agree to participate
You may not qualify if:
- Patients with critical illness.
- Patients with severe cognitive, hearing or visual impairment hindering proper communication
- Patients with physical disability that interfere with physical performance assessment or hand grip measurement
- Patient with any contraindication of to the use of BIA) e.g. presence of a pacemaker, other implanted electrical devices, or metal implants, volume overload
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, 11566, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Geriatrics and Gerontology
Study Record Dates
First Submitted
July 3, 2024
First Posted
July 23, 2024
Study Start
June 1, 2023
Primary Completion
April 30, 2024
Study Completion
April 30, 2024
Last Updated
July 23, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share